Remove Doctors Remove Government Remove Healthcare Provider
article thumbnail

Greece slaps Novartis with €214 million bribery suit

European Pharmaceutical Review

The Greek state has filed a lawsuit against Novartis , asking for € 214 million in compensation for non-pecuniary damages* the country may have suffered due to alleged illegal payments to government officials and healthcare providers. Novartis has, in recent years, paid $1.3

article thumbnail

How Counterfeit Medicines Challenge Pharma Sales in Malaysia

Contrarian Sales Techniques

Imagine spending weeks building trust with a doctor or pharmacist, only to find out that counterfeit versions of your product are circulating in the market. Counterfeit drugs don’t just hurt patients – they erode the trust we work so hard to build with healthcare providers and the public.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Philips on designing innovation and cultivating partnerships – part one

pharmaphorum

The biggest challenge seen in India is in healthcare spending. Overall, when looking at the private sector and government together, healthcare spending is close to 4% or 5% of India’s GDP, with the majority coming from the private sector. Still, the investment in infrastructure is abysmally low on the government side.

article thumbnail

Dr B raises $8m for telehealth service to deliver COVID antivirals

pharmaphorum

Paxlovid and Lagevrio were trumpeted on approval as being the key to quelling infections in milder cases of COVID-19, but despite sizeable orders from governments after they were authorised, demand among patients has been lacklustre, according to a recent report from health data analytics group Airfinity.

article thumbnail

Colombian healthcare reform aims to upend insurance and shift focus to primary care

Pharmaceutical Technology

After months of speculation, Colombia’s government has finally presented a long-awaited draft healthcare reform to congress. It includes a radical overhaul of the public healthcare insurance sector, doing away with the role of the Health Promoting Entities (Entidades Promotoras de Salud, EPS) as intermediaries.

article thumbnail

Patient centricity for tailor-made healthcare

European Pharmaceutical Review

At Clalit, which is the second largest healthcare provider in the world, I worked in several management positions and gained a broad understanding of the needs and constraints of a healthcare system. At Pfizer I promote the company’s interests and deliver value-based messages within the government arena.

article thumbnail

Reaching Crucial Hispanic Patient Audiences

PM360

By all metrics, this audience is active in managing their health: 90% practice self-care on a regular basis, 40% conduct their own research before seeing a doctor, 81% are actively trying to improve their health and 46% will “pay anything” when it concerns health. Meanwhile, the Hispanic population also has significant buying power.